跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Norepinephrine SciGen Concentrate for Solution for Infusion 4 mg/4mL - HSA Drug Approval Details
Approvals
/
HSA
/
Norepinephrine SciGen Concentrate for Solution for Infusion 4 mg/4mL
Approved
THERAPEUTIC
Norepinephrine SciGen Concentrate for Solution for Infusion 4 mg/4mL
Hefei Yifan Biopharmaceuticals Inc. (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 4, 2026
Approval ID
005d3815209ec7db
Company
Hefei Yifan Biopharmaceuticals Inc. (CHINA)
Type
Therapeutic
Approval Details
Approval Id
005d3815209ec7db
Drug Name
Norepinephrine SciGen Concentrate for Solution for Infusion 4 mg/4mL
Product Name
Norepinephrine SciGen Concentrate for Solution for Infusion 4 mg/4mL
Approval Number
SIN17453P
Approval Date
2026-02-04
Registrant
SCIGEN PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 4, 2026
Approval ID
005d3815209ec7db
Type
Therapeutic
Back to HSA Approvals